Ongoing research

The following list shows an overview of ongoing research projects, using SHM's data. The list is filtered to show only those projects that are made available to the general public. For more information about the research projects, please read our latest annual report

>> Latest annual report

 

SHM no Project title Author(s)
I23135 Investigating the regional internalised homonegativity, HIV stigma beliefs and their ecological associations with the regional HIV cascades among MSM in the Netherlands K. Jonas, H. Wang, H. Zimmerman, J. Kolstee, A. van Sighem
I23134 Two-Year Follow-up of SARS-CoV-2 Immunogenicity in People with HIV with CD4+ T-Cell Counts ≤350 versus >350 K. Brinkman, B. Rijnders, A. Roukens, C. Rokx, M. Jonkees
I23133 Attenuation of HIV severity by slightly deleterious mutations can explain the long-term trajectory of virulence evolution K. Lythgoe, H. Longley, C. Frase
I23132 Incidence of pneumococcal disease and herpes zoster in PLWH based on an integrated risk assessment for immunological status and age in order to make vaccination recommendations​​ A. Bruns, A. Verbon, B. van Welzen, E. te Linde
I23131 Predictors of early and late-stage hiv-diagnosis among individuals who acquired hiv-infection via (registered) heterosexual sex in four high-prevalent PHS-regions in the Netherlands (Haaglanden, Rotterdam-Rijnmond, Amsterdam, Utrecht) K. te Paske, J. Hontelez, J. Brand, M. van den Elshout,  E. Hoornenborg, H. Götz
I22128 SPIRIT (Strategies to prevent HIV transmission, Increase Retention in care and Improve Treatment outcome in the Dutch Caribbean) – substudy transmission dynamics   M. Hofstra, D. van de Wetering, B. Rodenburg, S. Autar, A. Rosingh, E. Wilkinson, J. van Kampen, C. Rokx, S. Jurriaans, M. van der Valk, T. van der Laar, J. den Hollander, D. Struik
I22126 Relationship between presence of the metabolic syndrome, metabolic dysfunction associated fatty liver disease and liver related outcomes in patients with HIV-HBV coinfection M.J. Sonneveld, M. van der Valk, L. Patmore, A. Boyd, C. Smit
I22122 Treatment of HIV-hepatitis B virus coinfection with and without tenofovir-containing antiretroviral therapy A. Mohareb, A. Boyd, C. Smit, E. Hyle, M. van der Valk
I22120 Spirit: Strategieën om verspreiding van hiv te voorkomen, de toegang tot en behoud in zorg te verbeteren en hiv-behandeling te optimaliseren D. van de Wetering, A. Duits, L. Hofstra, A. Wensing, G. Rozhnova
I21116 The therapeutic drug monitoring registry of antiretrovirals outcomes after bariatric surgery in the Netherlands- METAL - L. Zino, D.M. Burger, A. Colbers, O. Richel, C. Rokx, J. Stalenhoef
I21115 Outcomes of cervical cander screening in women living with HIV in Amsterdam M.F. Schim van der Loeff, S.E. Geerlings, J.A. Kramer, H.R. Verhoeve, S.J. Bogers, D.A.M. Heideman, M.C.G. Bleeker, K. Brinkman, K. Sigaloff, M. van der Valk
I21114 Know the local HIV epidemiology: map the numbers H. Götz, D. Twisk, J. den Hollander, C. Rokx, A. van Sighem
I21113 Prospects of HIV elimination among Dutch MSM by targeted screening, partner notification, and immediate ART initiation for acute HIV infection G. Rozhnova, M. Werkman, M. Kretzschmar, A. van Sighem, P. Reiss, J. Heijne, M. Dijkstra, W. Zuilof, G. de Bree, M. Schim van der Loeff  
I20111 Limburg 4 zero: An integrated approach to reduce the number of HIV and sexually transmitted infections in Limburg N. Dukers-Muijers, Y. Evers, H. Goense, R. Ackens, M. Pronk, R. van Crevel, O. Richel
I20110 Clinical outcomes and inflammation in viremic and non-viremic HIV elite controllers in the Dutch Athena Cohort A. Verbon, A. van der Ven, M. Netea, A. Groenendijk, W. Blok, M. Berrevoets
I19103

2000HIV Human Functional Genomics Partnership Programm (2000HIV study)

A. van der Ven, M. Netea, L. Joosten, Q. de Mast, M. Jacobs-Cleophas,  L. van Eekeren, M. Berrevoets, M. Blauw, A. Verbon, A. Groenendijk, W. Blok, W. Vos
I19100 HIV treatment outcomes of transgender people versus the general HIV-positive population in the Netherlands C. Daans, E. Hoornenborg, M. den Heijer, M. Prins
I18098 Geospatial analyse and mapping of new HIV diagnoses, late presentations and testing practices in Amsterdam - "het GIS project" within the H-TEAM initiative G. de Bree, M. Prins, L. Boehnke, C. Bozzacchi, P. Reiss, M. Heidenrijk, J. van Bergen, A. van Sighem, M. van Rooijen, M. Kroone, M. Groot-Bruinderink, O. Ratmann, E. op de Coul
I14065 Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients: Implications for screening strategies G. Wandeler, A. Rauch, P. Reiss, C. Smit, M. van der Valk, J. Arends
I13120 SPREAD Program 3.0 - Surveillance of transmission of HIV- drug resistace A.M.J. Wensing, C.A.B. Boucher, K. Brinkman, J. van der Meer, I. van de Ende, C. Richter, E. Schippers, D. de Vries-Sluijs, J. Schinkel, C. Smit
I12045 A HIV-1 genome wide association study to identify viral determinants of HIV-1 plasma concentration (BEEHIVE) F. de Wolf, B. Berkhout, M. Cornelissen, C. Fraser, P. Kellam, A. Gall, L. Gras, A. van Sighem
I08115 Proposal for collaboration and data exchange between HMF and RIVM for nation HIV/AIDS surveillance and data transfer to ECDC in the context of EU obligations for reporting on HIV/AIDS E. op den Coul, F. de Wolf, M. van der Sande, 
A. van Sighem, J. Vlug
I05513  HIV Resistance Response Database Initiative (RDI) A. Revell